Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Piconol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piconol SCHEMBL31122945 | 1.00 | — | — | |
| Piconol SCHEMBL29530498 | 0.97 | — | — | |
| Piconol SCHEMBL29266 | 0.97 | — | — | |
| Piconol SCHEMBL2909774 | 0.95 | HRH1 (0.48) | — | |
| Piconol SCHEMBL28642302 | 0.95 | HRH1 (0.52) | — | |
| Piconol SCHEMBL15050907 | 0.95 | — | — | |
| Piconol SCHEMBL7153449 | 0.95 | — | — | |
| Piconol SCHEMBL7153451 | 0.95 | — | — | |
| Piconol SCHEMBL3074525 | 0.95 | — | — | |
| Piconol SCHEMBL19874569 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111910256-A | Single crystal preparation method of caffeine impurity II | 山东新华制药股份有限公司 | 2020-11-10 | — | — | CN | claimed |
| CN-111910256-A | Single crystal preparation method of caffeine impurity II | 山东新华制药股份有限公司 | 2020-11-10 | — | — | CN | disclosed |
| EP-2221311-B1 | Novel nucleic acid base pair | TAGCYX BIOTECHNOLOGIES (JP) | 2013-08-21 | — | — | EP | disclosed |
| EP-1114827-B1 | NOVEL NUCLEIC ACID BASE PAIR | JAPAN SCIENCE & TECH AGENCY (JP) | 2010-11-17 | — | — | EP | disclosed |
| EP-2223931-A1 | Novel nucleic acid base pair | Japan Science and Technology Agency (JP) | 2010-09-01 | — | — | EP | disclosed |
| EP-2221311-A1 | Novel nucleic acid base pair | Japan Science and Technology Agency (JP) | 2010-08-25 | — | — | EP | disclosed |
| US-7667031-B2 | Nucleic acid base pair | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-02-23 | — | — | US | disclosed |
| US-20090286247-A1 | Novel nucleic acid base pair | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-11-19 | — | — | US | disclosed |
| US-7101992-B1 | Nucleic acid base pair | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2006-09-05 | — | — | US | disclosed |
| US-20050191689-A1 | Novel nucleic acid base pair | HIRAO, ICHIRO (JP) | 2005-09-01 | — | — | US | disclosed |
| EP-1114827-A1 | NOVEL NUCLEIC ACID BASE PAIR | Japan Science and Technology Corporation (JP) | 2001-07-11 | — | — | EP | disclosed |
| EP-0915875-A2 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LTD. (GB) | 1999-05-19 | — | — | EP | disclosed |
| WO-1998004559-A2 | SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 1998-02-05 | — | — | WO | disclosed |
| US-5166078-A | HAPTEN-MACROMOLECULE CONJUGATES USEFUL IN HAPTEN ASSAYS | IDEXX LABORATORIES, INC. (US) | 1992-11-24 | — | — | US | disclosed |
| EP-0256551-A2 | Hapten-macromolecule conjugates useful in hapten assays | AGRITECH SYSTEMS, Inc. (US) | 1988-02-24 | — | — | EP | disclosed |
| US-4656036-A | Antibiotics Tejeramycin and production thereof | MERCK & CO., INC. (US) | 1987-04-07 | — | — | US | disclosed |
| US-4482708-A | VIRICIDES; POTENTIATION AND INDUCTION OF INTERFERON PRODUCTION | NGUYEN NICOLAS C | 1984-11-13 | — | — | US | disclosed |